California Institute for Regenerative Medicine– tag –
-
UC Santa Barbara Researchers Successfully Restore Vision in Two AMD Patients with Stem Cell Retinal Patch
CIRM (California Institute for Regenerative Medicine) UK Overview A stem cell-based retinal patch developed by UC Santa Barbara researchers successfully restored vision in two UK patients suffering from age-related macular degeneration (... -
CHOC Shapes Future of Pediatric Gene Therapy: Driving Early Intervention with CRISPR Editing and Strict Quality Control
Children's Hospital of Orange County (CHOC) Pediatrica USA Overview Rady Children's Health Orange County is focusing on in vivo gene replacement, ex vivo gene therapy (e.g., CAR T-cell therapy), and CRISPR-based genome editing to shape t... -
Siren Biotechnology Secures $8 Million Non-Dilutive Funding from CIRM to Advance Brain Tumor Gene Therapy SRN-101
Phacilitate USA Overview Siren Biotechnology has been awarded $8 million in non-dilutive funding from the California Institute for Regenerative Medicine (CIRM). This significant capital injection will be used to support the clinical deve... -
First-in-Human Pluripotent Stem Cell-Derived Neural Stem Cell Therapy for Huntington’s Disease (Regen4HD) Reports Phase 1b/2a Updates at ISSCR 2026
PharmaTimes USA Overview Updates from the first-in-human Phase 1b/2a clinical trial of Regen4HD, a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease, were presented at the ISSCR 2026 Annual Meeting. This lan... -
FDA Approves Allogeneic Cell Therapy TREGZI for GVHD; New Advanced Cell Therapy Association Launches in Europe
RegMedNet UK Overview The FDA has approved Orca Bio's allogeneic cell therapy TREGZI (Orc-T®) for graft-versus-host disease (GVHD), based on positive Phase 3 Precision-T trial results, aiming to mitigate GVHD and reconstruct immunity. Si...
1